Alexander disease: models, mechanisms, and medicine

• Published in: Current opinion in neurobiology Vol. 72; pp. 140 - 147
• Main Author: Hagemann, Tracy L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.02.2022
• Subjects: Alexander Disease - genetics; Alexander Disease - metabolism; Alexander Disease - pathology; Animals; Astrocytes - metabolism; Central Nervous System - pathology; Glial Fibrillary Acidic Protein - genetics; Glial Fibrillary Acidic Protein - metabolism; Humans; Mutation; Protein Aggregates
• ISSN: 0959-4388; 1873-6882
• DOI: 10.1016/j.conb.2021.10.002

Alexander disease is a primary disorder of astrocytes caused by gain-of-function mutations in the gene for glial fibrillary acidic protein (GFAP), which lead to protein aggregation and a reactive astrocyte response, with devastating effects on the central nervous system. Over the past two decades since the discovery of GFAP as the culprit, several cellular and animal models have been generated, and much has been learned about underlying mechanisms contributing to the disease. Despite these efforts, many aspects of Alexander disease have remained enigmatic, particularly the initiating events in GFAP accumulation and astrocyte pathology, the relation between astrocyte dysfunction and myelin deficits, and the variability in age of onset and disease severity. More recent work in both old and new models has begun to address these complex questions and identify new therapeutics that finally offer the promise of effective treatment.